PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer
Gespeichert in:
| Autor*in: |
Englisch, C. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Übergeordnetes Werk: |
Enthalten in: DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer - 2012, vascular obstruction, hemorrhage and hemostasis, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:213 ; year:2022 ; pages:12 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0049-3848(22)00191-8 |
|---|
| Katalog-ID: |
ELV057586926 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV057586926 | ||
| 003 | DE-627 | ||
| 005 | 20230625002451.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220808s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0049-3848(22)00191-8 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica |
| 035 | |a (DE-627)ELV057586926 | ||
| 035 | |a (ELSEVIER)S0049-3848(22)00191-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Englisch, C. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| 264 | 1 | |c 2022 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 700 | 1 | |a Königsbrugge, O. |4 oth | |
| 700 | 1 | |a Moik, F. |4 oth | |
| 700 | 1 | |a Quehenberger, P. |4 oth | |
| 700 | 1 | |a Preusser, M. |4 oth | |
| 700 | 1 | |a Pabinger, I. |4 oth | |
| 700 | 1 | |a Ay, C. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |d 2012 |d vascular obstruction, hemorrhage and hemostasis |g Amsterdam [u.a.] |w (DE-627)ELV011105356 |
| 773 | 1 | 8 | |g volume:213 |g year:2022 |g pages:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0049-3848(22)00191-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_40 | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 213 |j 2022 |h 12 |y 213.2022, S12- | ||
| author_variant |
c e ce |
|---|---|
| matchkey_str |
englischcknigsbruggeomoikfquehenbergerpp:2022----:o3nihobnciiynascainihikfhobssnmra |
| hierarchy_sort_str |
2022 |
| bklnumber |
44.40 |
| publishDate |
2022 |
| allfields |
10.1016/S0049-3848(22)00191-8 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV057586926 (ELSEVIER)S0049-3848(22)00191-8 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Englisch, C. verfasserin aut PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Königsbrugge, O. oth Moik, F. oth Quehenberger, P. oth Preusser, M. oth Pabinger, I. oth Ay, C. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:213 year:2022 pages:12 https://doi.org/10.1016/S0049-3848(22)00191-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 213 2022 12 213.2022, S12- |
| spelling |
10.1016/S0049-3848(22)00191-8 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV057586926 (ELSEVIER)S0049-3848(22)00191-8 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Englisch, C. verfasserin aut PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Königsbrugge, O. oth Moik, F. oth Quehenberger, P. oth Preusser, M. oth Pabinger, I. oth Ay, C. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:213 year:2022 pages:12 https://doi.org/10.1016/S0049-3848(22)00191-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 213 2022 12 213.2022, S12- |
| allfields_unstemmed |
10.1016/S0049-3848(22)00191-8 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV057586926 (ELSEVIER)S0049-3848(22)00191-8 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Englisch, C. verfasserin aut PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Königsbrugge, O. oth Moik, F. oth Quehenberger, P. oth Preusser, M. oth Pabinger, I. oth Ay, C. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:213 year:2022 pages:12 https://doi.org/10.1016/S0049-3848(22)00191-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 213 2022 12 213.2022, S12- |
| allfieldsGer |
10.1016/S0049-3848(22)00191-8 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV057586926 (ELSEVIER)S0049-3848(22)00191-8 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Englisch, C. verfasserin aut PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Königsbrugge, O. oth Moik, F. oth Quehenberger, P. oth Preusser, M. oth Pabinger, I. oth Ay, C. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:213 year:2022 pages:12 https://doi.org/10.1016/S0049-3848(22)00191-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 213 2022 12 213.2022, S12- |
| allfieldsSound |
10.1016/S0049-3848(22)00191-8 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica (DE-627)ELV057586926 (ELSEVIER)S0049-3848(22)00191-8 DE-627 ger DE-627 rakwb eng 610 VZ 610 VZ 44.40 bkl Englisch, C. verfasserin aut PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Königsbrugge, O. oth Moik, F. oth Quehenberger, P. oth Preusser, M. oth Pabinger, I. oth Ay, C. oth Enthalten in Elsevier Science DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer 2012 vascular obstruction, hemorrhage and hemostasis Amsterdam [u.a.] (DE-627)ELV011105356 volume:213 year:2022 pages:12 https://doi.org/10.1016/S0049-3848(22)00191-8 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 44.40 Pharmazie Pharmazeutika VZ AR 213 2022 12 213.2022, S12- |
| language |
English |
| source |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:213 year:2022 pages:12 |
| sourceStr |
Enthalten in DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer Amsterdam [u.a.] volume:213 year:2022 pages:12 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| authorswithroles_txt_mv |
Englisch, C. @@aut@@ Königsbrugge, O. @@oth@@ Moik, F. @@oth@@ Quehenberger, P. @@oth@@ Preusser, M. @@oth@@ Pabinger, I. @@oth@@ Ay, C. @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011105356 |
| dewey-sort |
3610 |
| id |
ELV057586926 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057586926</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625002451.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0049-3848(22)00191-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057586926</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(22)00191-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Englisch, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Königsbrugge, O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moik, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Quehenberger, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Preusser, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pabinger, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ay, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:213</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0049-3848(22)00191-8</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">213</subfield><subfield code="j">2022</subfield><subfield code="h">12</subfield><subfield code="y">213.2022, S12-</subfield></datafield></record></collection>
|
| author |
Englisch, C. |
| spellingShingle |
Englisch, C. ddc 610 bkl 44.40 PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| authorStr |
Englisch, C. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011105356 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.40 bkl PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| topic |
ddc 610 bkl 44.40 |
| topic_unstemmed |
ddc 610 bkl 44.40 |
| topic_browse |
ddc 610 bkl 44.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
o k ok f m fm p q pq m p mp i p ip c a ca |
| hierarchy_parent_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| hierarchy_parent_id |
ELV011105356 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011105356 |
| title |
PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| ctrlnum |
(DE-627)ELV057586926 (ELSEVIER)S0049-3848(22)00191-8 |
| title_full |
PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| author_sort |
Englisch, C. |
| journal |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| journalStr |
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
12 |
| author_browse |
Englisch, C. |
| container_volume |
213 |
| class |
610 VZ 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Englisch, C. |
| doi_str_mv |
10.1016/S0049-3848(22)00191-8 |
| dewey-full |
610 |
| title_sort |
po-03: antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| title_auth |
PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-PHA GBV_ILN_24 GBV_ILN_40 |
| title_short |
PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer |
| url |
https://doi.org/10.1016/S0049-3848(22)00191-8 |
| remote_bool |
true |
| author2 |
Königsbrugge, O. Moik, F. Quehenberger, P. Preusser, M. Pabinger, I. Ay, C. |
| author2Str |
Königsbrugge, O. Moik, F. Quehenberger, P. Preusser, M. Pabinger, I. Ay, C. |
| ppnlink |
ELV011105356 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/S0049-3848(22)00191-8 |
| up_date |
2024-07-06T16:34:36.052Z |
| _version_ |
1803848175904096256 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057586926</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625002451.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0049-3848(22)00191-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001781.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057586926</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0049-3848(22)00191-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Englisch, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">PO-03: Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Königsbrugge, O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moik, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Quehenberger, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Preusser, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pabinger, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ay, C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer</subfield><subfield code="d">2012</subfield><subfield code="d">vascular obstruction, hemorrhage and hemostasis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011105356</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:213</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0049-3848(22)00191-8</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">213</subfield><subfield code="j">2022</subfield><subfield code="h">12</subfield><subfield code="y">213.2022, S12-</subfield></datafield></record></collection>
|
| score |
7.4013987 |